Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 17378911)

Published in Am J Gastroenterol on March 22, 2007

Authors

Catherine de Martel1, Thomas D Haggerty, Douglas A Corley, Joseph H Vogelman, Norman Orentreich, Julie Parsonnet

Author Affiliations

1: Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California 94305, USA.

Articles citing this

Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) (2008) 3.97

Association of adiponectin multimers with Barrett's oesophagus. Gut (2009) 1.43

Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus. Gastroenterology (2013) 1.09

Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol (2013) 1.09

Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study. Int J Cancer (2011) 1.00

The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst (2011) 0.91

Helicobacter pylori infection and circulating ghrelin levels - a systematic review. BMC Gastroenterol (2011) 0.88

A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol (2014) 0.85

Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol (2014) 0.84

Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation. World J Gastroenterol (2014) 0.83

Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma. Gut (2011) 0.82

Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol (2016) 0.81

Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis. PLoS One (2013) 0.80

Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut (2007) 0.79

Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review. Endocr Relat Cancer (2016) 0.77

Risk factors for neoplastic progression in Barrett's esophagus. World J Gastroenterol (2011) 0.77

Associations of Circulating Gut Hormone and Adipocytokine Levels with the Spectrum of Gastroesophageal Reflux Disease. PLoS One (2015) 0.76

The Influence of Ghrelin on the Development of Dextran Sodium Sulfate-Induced Colitis in Rats. Biomed Res Int (2015) 0.76

Articles by these authors

Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA (2013) 4.67

Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Proc Natl Acad Sci U S A (2008) 2.84

Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology (2007) 2.76

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 2.59

The complete genome of klassevirus - a novel picornavirus in pediatric stool. Virol J (2009) 2.46

Nutritional control of aging. Exp Gerontol (2003) 2.35

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33

Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis (2005) 2.28

Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15

Engaging students in dedicated research and scholarship during medical school: the long-term experiences at Duke and Stanford. Acad Med (2010) 2.12

Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med (2014) 2.05

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol (2006) 2.00

Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol (2008) 1.86

Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol (2011) 1.78

Chronic kidney disease and risk of renal cell carcinoma: differences by race. Epidemiology (2015) 1.78

CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis (2002) 1.72

Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol (2004) 1.72

Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis (2011) 1.68

Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med (2014) 1.68

A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67

Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis (2004) 1.63

Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay. J Clin Microbiol (2012) 1.63

Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst (2010) 1.60

A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58

Commentary: H. pylori infection in early life and the problem of imperfect tests. Int J Epidemiol (2005) 1.57

Helicobacter pylori infection and gastric cancer--for want of more outcomes. JAMA (2004) 1.57

Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Chest (2003) 1.56

The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc (2002) 1.54

Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction. Aging Cell (2006) 1.53

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52

Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer (2002) 1.48

Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One (2012) 1.48

Vitamin d deficiency and tuberculosis progression. Emerg Infect Dis (2010) 1.46

Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One (2010) 1.45

Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology (2011) 1.44

Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med (2008) 1.38

Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut (2013) 1.37

Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay. J Clin Microbiol (2010) 1.36

Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev (2004) 1.34

Encouraging scholarship: medical school programs to promote student inquiry beyond the traditional medical curriculum. Acad Med (2010) 1.33

Dietary methionine restriction enhances metabolic flexibility and increases uncoupled respiration in both fed and fasted states. Am J Physiol Regul Integr Comp Physiol (2010) 1.31

Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol (2012) 1.30

Use of insecticide-treated nets (ITNs) following a malaria education intervention in Piron, Mali: a control trial with systematic allocation of households. Malar J (2005) 1.29

Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology (2012) 1.28

Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst (2013) 1.25

Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density. PLoS One (2012) 1.23

The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett's Esophagus. Gastrointest Endosc (2012) 1.23

Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 1.22

Role of beta-adrenergic receptors in the hyperphagic and hypermetabolic responses to dietary methionine restriction. Am J Physiol Regul Integr Comp Physiol (2010) 1.21

Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology (2008) 1.19

Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut (2011) 1.18

Gastroenteritis and transmission of Helicobacter pylori infection in households. Emerg Infect Dis (2006) 1.18

Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome. J Clin Endocrinol Metab (2011) 1.18

Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci (2009) 1.17

Urinary triclosan is associated with elevated body mass index in NHANES. PLoS One (2013) 1.15

Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.14

Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev (2002) 1.14

Methionine restriction effects on 11 -HSD1 activity and lipogenic/lipolytic balance in F344 rat adipose tissue. J Lipid Res (2007) 1.13

Methionine restriction effects on mitochondrial biogenesis and aerobic capacity in white adipose tissue, liver, and skeletal muscle of F344 rats. Metabolism (2010) 1.13

Risk of intestinal helminth and protozoan infection in a refugee population. Am J Trop Med Hyg (2005) 1.11

Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med (2013) 1.11

Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10

Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci (2006) 1.09

Natural acquisition of Helicobacter pylori infection in newborn rhesus macaques. J Clin Microbiol (2003) 1.08

Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr Res Rev (2010) 1.05

Significance of transiently positive enzyme-linked immunosorbent assay results in detection of Helicobacter pylori in stool samples from children. J Clin Microbiol (2005) 1.05

Role of bacteria in oncogenesis. Clin Microbiol Rev (2010) 1.05

Helicobacter pylori and risk of gastroenteritis. J Infect Dis (2004) 1.05

Maternal prepregnancy body mass index and risk of spontaneous preterm birth. Paediatr Perinat Epidemiol (2014) 1.04

Tissue glutathione and cysteine levels in methionine-restricted rats. Nutrition (2004) 1.04

Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol (2008) 1.04

Genomic and metabolic responses to methionine-restricted and methionine-restricted, cysteine-supplemented diets in Fischer 344 rat inguinal adipose tissue, liver and quadriceps muscle. J Nutrigenet Nutrigenomics (2012) 1.04

Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol (2008) 1.03

Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am J Gastroenterol (2007) 1.03

Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer (2010) 1.03

Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. J Invest Dermatol (2009) 1.01

Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies. Clin Chem (2002) 0.97

Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. Am J Epidemiol (2005) 0.97

Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter (2008) 0.97

Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control (2008) 0.97

Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States. J Infect Dis (2009) 0.97

Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study. BMC Cardiovasc Disord (2011) 0.95

Cerebral myiasis associated with angiosarcoma of the scalp: case report. Neurosurgery (2007) 0.95

Metabolic adaptations to methionine restriction that benefit health and lifespan in rodents. Exp Gerontol (2012) 0.95

Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis. J Gastroenterol (2013) 0.95

The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol (2012) 0.95